JAK2 rs10758669 polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: A meta-analysis

Inflammation

Volumn 37, Issue 3, 2014, Pages 793-800

  Zhang, Ji Xiang ^a   Song, Jia ^a   Wang, Jun ^a   Dong, Wei Guo ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Crohn's disease; JAK2; meta analysis; polymorphisms; ulcerative colitis

Indexed keywords

JANUS KINASE 2; JAK2 PROTEIN, HUMAN;

ARTICLE; ASIAN; CAUCASIAN; CROHN DISEASE; ETHNICITY; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; GROUPS BY AGE; HUMAN; JANUS KINASE 2 GENE; ONSET AGE; SINGLE NUCLEOTIDE POLYMORPHISM; STUDY DESIGN; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; RISK; RISK FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; COLITIS, ULCERATIVE; CROHN DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JANUS KINASE 2; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84902540404     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9798-5     Document Type: Article

References (36)

1. Leone V, Chang EB, Devkota S. 2011. Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases. J Gastroenterol. 2013; 48: 315-321.
2. Hammer HF. Gut microbiota and inflammatory bowel disease. Dig Dis 29: 550-553.
3. Molodecky, N.A., I.S. Soon, D.M. Rabi, W.A. Ghali, M. Ferris, G. Chernoff, E.I. Benchimol, R. Panaccione, S. Ghosh, H.W. Barkema, and G.G. Kaplan. 2012. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142: 46-54.
4. Xavier, R.J., and D.K. Podolsky. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434. (Pubitemid 47123518)
5. Loftus Jr., E.V. 2004. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 26: 1504-1517. (Pubitemid 38649869)
6. Neuman, M.G., and R.M. Nanau. 2012. Single-nucleotide polymorphisms in inflammatory bowel disease. Transl Res 160: 45-64.
7. Brand, S. 2009. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 58: 1152-1167.
8. Coskun, M., M. Salem, J. Pedersen, and O.H. Nielsen. 2013. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease. Pharmacol Res 76C: 1-8.
9. Ivanov, I.I., B.S. McKenzie, L. Zhou, C.E. Tadokoro, A. Lepelley, J.J. Lafaille, D.J. Cua, and D.R. Littman. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133. (Pubitemid 44380299)
10. Medrano, L.M., M. García-Magariños, B. Dema, L. Espino, C. Maluenda, I. Polanco, M.Á. Figueredo, M. Fernández-Arquero, and C. Núñez. 2012. Th17-related genes and celiac disease susceptibility. PLoS One 7: e31244.
11. Mahy, G., J. Mansfield, A.R. Morgan, C. Mowat, W. Newman, O. Palmieri, C.Y. Ponsioen, U. Potocnik, N.J. Prescott, M. Regueiro, J.I. Rotter, R.K. Russell, J.D. Sanderson, M. Sans, J. Satsangi, S. Schreiber, L.A. Simms, J. Sventoraityte, S.R. Targan, K.D. Taylor, M. Tremelling, H.W. Verspaget, M. De Vos, C. Wijmenga, D.C. Wilson, J. Winkelmann, R.J. Xavier, S. Zeissig, B. Zhang, C.K. Zhang, H. Zhao, International IBD Genetics Consortium (IIBDGC), M.S. Silverberg, V. Annese, H. Hakonarson, S.R. Brant, G. Radford-Smith, C.G. Mathew, J.D. Rioux, E.E. Schadt, M.J. Daly, A. Franke, M. Parkes, S. Vermeire, J.C. Barrett, and J.H. Cho. 2012. Hostmicrobe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491: 119-124.
12. Jung, C., J.F. Colombel, M. Lemann, L. Beaugerie, M. Allez, J. Cosnes, G. Vernier-Massouille, J.M. Gornet, J.P. Gendre, J.P. Cezard, F.M. Ruemmele, D. Turck, F. Merlin, H. Zouali, C. Libersa, P. Dieudé, N. Soufir, G. Thomas, and J.P. Hugot. 2012. Genotype/phenotype analyses for 53 Crohn's disease associated genetic polymorphisms. PLoS One 7: e52223.
13. Anderson, C.A., D.C. Massey, J.C. Barrett, N.J. Prescott, M. Tremelling, S.A. Fisher, R. Gwilliam, J. Jacob, E.R. Nimmo, H. Drummond, C.W. Lees, C.M. Onnie, C. Hanson, K. Blaszczyk, R. Ravindrarajah, S. Hunt, D. Varma, N. Hammond, G. Lewis, H. Attlesey, N. Watkins, W. Ouwehand, D. Strachan, W. McArdle, C.M. Lewis, Wellcome Trust Case Control Consortium, A. Lobo, J. Sanderson, D.P. Jewell, P. Deloukas, J.C. Mansfield, C.G. Mathew, J. Satsangi, and M. Parkes. 2009. Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 136: 523-552.
14. Polgar, N., V. Csongei, M. Szabo, V. Zambo, B.I. Melegh, K. Sumegi, G. Nagy, Z. Tulassay, and B. Melegh. 2012. Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene-gene interactions in inflammatory bowel disease. Int J Immunogenet 39: 247-252.
15. Danoy, P., K. Pryce, J. Hadler, L.A. Bradbury, C. Farrar, J. Pointon, Australo-Anglo-American Spondyloarthritis Consortium, M. Ward, M. Weisman, J.D. Reveille, B.P. Wordsworth, M. Stone, Spondyloarthritis Research Consortium of Canada, W.P. Maksymowych, P. Rahman, D. Gladman, R.D. Inman, and M.A. Brown. 2010. Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease. PLoS Genet 6: e1001195.
16. Ferguson, L.R., D.Y. Han, A.G. Fraser, C. Huebner, W.J. Lam, A.R. Morgan, H. Duan, and N. Karunasinghe. 2010. Genetic factors in chronic inflammation: single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population. Mutat Res 690: 108-115.
17. Yang, S.K., Y. Jung, H. Kim, M. Hong, B.D. Ye, and K. Song. 2011. Association of FCGR2A, JAK2 or HNF4A variants with ulcerative colitis in Koreans. Dig Liver Dis 43: 856-861.
18. Amre, D.K., D.R. Mack, K. Morgan, D. Israel, C. Deslandres, E.G. Seidman, P. Lambrette, I. Costea, A. Krupoves, H. Fegury, J. Dong, Z. Xhu, G. Grimard, and E. Levy. 2010. Association between genome-wide association studies reported SNPs and pediatric-onset Crohn's disease in Canadian children. Hum Genet 128: 131-135.
19. Hirano, A., K. Yamazaki, J. Umeno, K. Ashikawa, M. Aoki, T. Matsumoto, S. Nakamura, T. Ninomiya, T. Matsui, F. Hirai, T. Kawaguchi, M. Takazoe, H. Tanaka, S. Motoya, Y. Kiyohara, T. Kitazono, Y. Nakamura, N. Kamatani, and M. Kubo. 2013. Association study of 71 European Crohn's disease susceptibility loci in a Japanese population. Inflamm Bowel Dis 19: 526-533.
20. Asano, K., T. Matsushita, J. Umeno, N. Hosono, A. Takahashi, T. Kawaguchi, T. Matsumoto, T. Matsui, Y. Kakuta, Y. Kinouchi, T. Shimosegawa, M. Hosokawa, Y. Arimura, Y. Shinomura, Y. Kiyohara, T. Tsunoda, N. Kamatani, M. Iida, Y. Nakamura, and M. Kubo. 2009. A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nat Genet 41: 1325-1329.
21. Silverberg, M.S., J.H. Cho, J.D. Rioux, D.P. McGovern, J. Wu, V. Annese, J.P. Achkar, P. Goyette, R. Scott, W. Xu, M.M. Barmada, L. Klei, M.J. Daly, C. Abraham, T.M. Bayless, F. Bossa, A.M. Griffiths, A.F. Ippoliti, R.G. Lahaie, A. Latiano, P. Paré, D.D. Proctor, M.D. Regueiro, A.H. Steinhart, S.R. Targan, L.P. Schumm, E.O. Kistner, A.T. Lee, P.K. Gregersen, J.I. Rotter, S.R. Brant, K.D. Taylor, K. Roeder, and R.H. Duerr. 2009. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 41: 216-220.
22. Prager, M., J. Büttner, V. Haas, D.C. Baumgart, A. Sturm, M. Zeitz, and C. Büning. 2012. The JAK2 variant rs10758669 in Crohn's disease: altering the intestinal barrier as one mechanism of action. Int J Colorectal Dis 27: 565-573.
23. Latella, G., and C. Papi. 2012. Crucial steps in the natural history of inflammatory bowel disease. World J Gastroenterol 18: 3790-3799.
24. Tsianos, E.V., K.H. Katsanos, and V.E. Tsianos. 2012. Role of genetics in the diagnosis and prognosis of Crohn's disease. World J Gastroenterol 18: 105-118.
25. Stone, C.D. 2012. The economic burden of inflammatory bowel disease: Clear problem, unclear solution. Dig Dis Sci 57: 3042-3044.
26. Abraham, C., and J.H. Cho. 2009. Inflammatory bowel disease. N Engl J Med 361: 2066-2078.
27. Thompson, A.I., and C.W. Lees. 2011. Genetics of ulcerative colitis. Inflamm Bowel Dis 17: 831-848.
28. Lee, J.C., and M. Parkes. 2011. Genome-wide association studies and Crohn's disease. Brief Funct Genomics 10(7): 1-76.
29. Murray, P.J. 2007. The JAK-STAT signaling pathway: Input and output integration. J Immunol 178: 2623-2629. (Pubitemid 46333135)
30. Parham, C., M. Chirica, J. Timans, E. Vaisberg, M. Travis, J. Cheung, S. Pflanz, R. Zhang, K.P. Singh, F. Vega, W. To, J. Wagner, A.M. O'Farrell, T. McClanahan, S. Zurawski, C. Hannum, D. Gorman, D.M. Rennick, R.A. Kastelein, Malefyt R. de Waal, and K.W. Moore. 2002. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 168: 5699-5708. (Pubitemid 34556153)
31. Szabo, S.J., S.T. Kim, G.L. Costa, X. Zhang, C.G. Fathman, and L.H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
32. Stritesky, G.L., R. Muthukrishnan, S. Sehra, R. Goswami, D. Pham, J. Travers, E.T. Nguyen, D.E. Levy, and M.H. Kaplan. 2011. The transcription factor STAT3 is required for T helper 2 cell development. Immunity 34: 39-49.
33. Durant, L., W.T. Watford, H.L. Ramos, A. Laurence, G. Vahedi, L. Wei, H. Takahashi, H.W. Sun, Y. Kanno, F. Powrie, and J.J. O'Shea. 2010. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 32: 605-615.
34. Strober, W. 2008. Why study animal models of IBD? Inflamm Bowel Dis 14(Suppl 2): S129-S131.
35. Imielinski, M., R.N. Baldassano, A. Griffiths, R.K. Russell, V. Annese, M. Dubinsky, S. Kugathasan, J.P. Bradfield, T.D. Walters, P. Sleiman, C.E. Kim, A. Muise, K. Wang, J.T. Glessner, S. Saeed, H. Zhang, E.C. Frackelton, C. Hou, J.H. Flory, G. Otieno, R.M. Chiavacci, R. Grundmeier, M. Castro, A. Latiano, B. Dallapiccola, J. Stempak, D.J. Abrams, K. Taylor, D. McGovern, Western Regional Alliance for Pediatric IBD, G. Silber, I. Wrobel, A. Quiros, International IBD Genetics Consortium, C. Libioulle, C. Sandor, M. Lathrop, J. Belaiche, O. Dewit, I. Gut, S. Heath, D. Laukens, M. Mni, P. Rutgeerts, A. Van Gossum, D. Zelenika, D. Franchimont, J.P. Hugot, M. de Vos, S. Vermeire, E. Louis, Belgian-French IBD Consortium; Wellcome Trust Case Control Consortium, L.R. Cardon, C.A. Anderson, H. Drummond, E. Nimmo, T. Ahmad, N.J. Prescott, C.M. Onnie, S.A. Fisher, J. Marchini, J. Ghori, S. Bumpstead, R. Gwillam, M. Tremelling, P. Delukas, J. Mansfield, D. Jewell, J. Satsangi, C.G. Mathew, M. Parkes, M. Georges, M.J. Daly, M.B. Heyman, G.D. Ferry, B. Kirschner, J. Lee, J. Essers, R. Grand, M. Stephens, A. Levine, D. Piccoli, J. Van Limbergen, S. Cucchiara, D.S. Monos, S.L. Guthery, L. Denson, D.C. Wilson, S.F. Grant, M. Daly, M.S. Silverberg, J. Satsangi, and H. Hakonarson. 2009. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet 41: 1335.
36. Essers, J.B., J.J. Lee, S. Kugathasan, C.R. Stevens, R.J. Grand, M.J. Daly, and NIDDK IBD Genetics Consortium. 2009. Established genetic risk factors do not distinguish early and later onset Crohn's disease. Inflamm Bowel Dis 15: 1508-1514.